Infarct-Size Limitation by Preconditioning is Enhanced by Dipyridamole Administered Before But Not After Preconditioning: Evidence for the Role of Interstitial Adenosine Level During Preconditioning as a Primary Determinant of Cardioprotection (Q47296073)
Jump to navigation
Jump to search
scientific article published on January 1, 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infarct-Size Limitation by Preconditioning is Enhanced by Dipyridamole Administered Before But Not After Preconditioning: Evidence for the Role of Interstitial Adenosine Level During Preconditioning as a Primary Determinant of Cardioprotection |
scientific article published on January 1, 1998 |
Statements
1 reference
Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection (English)
1 reference
Infarct-Size Limitation by Preconditioning is Enhanced by Dipyridamole Administered Before But Not After Preconditioning: Evidence for the Role of Interstitial Adenosine Level During Preconditioning as a Primary Determinant of Cardioprotection (English)
K. Suzuki
T. Miki
A. Tsuchida
1 January 1998
1 reference
31
1 reference
1
1 reference
1-9
1 reference